Boutaibi Houssam, Azzouzi Hamida, Chennouf Fadoua, Ichchou Linda
Department of Rheumatology, Mohammed VI University Hospital of Oujda, Faculty of medicine and pharmacy, Mohammed First University, BP 4806 Oujda Université, 60049 Oujda, Morocco.
Bone Rep. 2024 Sep 23;23:101806. doi: 10.1016/j.bonr.2024.101806. eCollection 2024 Dec.
The aim was to assess the association and predictive value of trabecular bone score (TBS), fracture risk assessment tool (FRAX), and TBS-adjusted FRAX with prevalent vertebral fractures (VFs) in patients with rheumatoid arthritis (RA).
Patients diagnosed with RA were included in this cross-sectional study. Clinical data and laboratory tests were collected on the same day as the dual-energy x-ray absorptiometry (DXA) scan. TBS, bone mineral density (BMD), and vertebral fracture assessment (VFA) were obtained from the DXA scan. We used the FRAX tool to assess the 10-year probability of major osteoporotic fracture (MOF-FRAX) and hip fracture (HF-FRAX) with and without BMD. These parameters were further adjusted for TBS. Patients with prevalent VFs were defined as those with moderate to severe VFs from T4 to L4. VFs presence was used as the binary variable in the logistic regressions and receiving operator characteristics (ROC) curves analysis.
Sixty-nine patients were enrolled, with 55.1 % being postmenopausal. The mean TBS was 1.328 ± 0.104. Osteoporosis according to the WHO criteria was present in 39 patients (56.5 %), and six patients (8.7 %) had VFs with thoracic predominance (66.67 %). Univariate and multivariate logistic regression analyses did not show an association between TBS and vertebral fractures, but FRAX scores indicated such an association. The area under the curve (AUC) with 95 % confidence intervals (CI) for the MOF-FRAX score with BMD, MOF-FRAX score without BMD, TBS-adjusted MOF-FRAX score, and TBS were 0.837 [0.686-0.988], 0.795 [0.629-0.961], 0.778 [0.571-0.984], and 0.515 [0.298-0.731], respectively.
In our RA patients, FRAX scores were associated with vertebral fractures (VFs), while TBS was not. The MOF-FRAX score combined with BMD, showed the best AUC for VFs in this population.
旨在评估小梁骨评分(TBS)、骨折风险评估工具(FRAX)以及经TBS调整的FRAX与类风湿关节炎(RA)患者中现患椎体骨折(VF)的相关性及预测价值。
本横断面研究纳入诊断为RA的患者。在进行双能X线吸收法(DXA)扫描的同一天收集临床数据和实验室检查结果。从DXA扫描中获取TBS、骨密度(BMD)和椎体骨折评估(VFA)。我们使用FRAX工具评估有和无BMD时主要骨质疏松性骨折(MOF - FRAX)和髋部骨折(HF - FRAX)的10年概率。这些参数进一步根据TBS进行调整。现患VF的患者定义为T4至L4存在中度至重度VF的患者。VF的存在用作逻辑回归和受试者工作特征(ROC)曲线分析中的二元变量。
共纳入69例患者,其中55.1%为绝经后女性。平均TBS为1.328±0.104。根据WHO标准,39例患者(56.5%)存在骨质疏松,6例患者(8.7%)有以胸椎为主的VF(66.67%)。单因素和多因素逻辑回归分析未显示TBS与椎体骨折之间存在关联,但FRAX评分显示存在这种关联。有BMD的MOF - FRAX评分、无BMD的MOF - FRAX评分、经TBS调整的MOF - FRAX评分以及TBS的曲线下面积(AUC)及其95%置信区间(CI)分别为0.837 [0.686 - 0.988]、0.795 [0.629 - 0.961]、0.778 [0.571 - 0.984]和0.515 [0.298 - 0.731]。
在我们的RA患者中,FRAX评分与椎体骨折(VF)相关,而TBS不相关。在该人群中,结合BMD的MOF - FRAX评分对VF显示出最佳的AUC。